Drug Trial Radar · NCT06172998
New Perspective on Exploring the Post-apneic BP Surge in Patients With OSA
Last checked: Nov 19, 2026Latest source record: Dec 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
350
Planned (sponsor's estimate)
Start
Apr 1, 2022
Primary completion
Apr 1, 2024
Study completion Jun 1, 2024
Sponsor
- Lead sponsor
- Xu JAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 15, 2023
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The nocturnal short-term BPV induced by sleep-breathing events is affected by many factors. The purpose of the study is as follows: (1) to explore the relationship between nocturnal short-term BPV and vascular endothelial function and sympathetic activity in patients with OSA respectively, (2) to explore which play the key role in BP fluctuation, (3) how to prevent the frequent BP fluctuation and arrive at a safe point.
Conditions
- Obstructive Sleep Apnea
Interventions
Phentolamine InjectionDrug
Under patient safety, Phentolamine will be pumped into the OSA patients equipped with PSG and ECG monitoring in a safe dose to prevent sympathetic overactivity. Under patient safety, Nitroglycerin will be pumped into the OSA patients equipped with PSG and ECG monitoring in a safe dose to prevent endothelial dysfunction.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with high nocturnal short-term BPV will changeTime frame: one night
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Jing Xu
Huai'an, Jiangsu, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.